Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2008, Vol. 2 Issue (4) : 374-379     DOI: 10.1007/s11684-008-0072-4
Effect on proliferation and apoptosis of T24 cell lines via silencing DNMT1 with RNA interference
ZHANG Shilong, ZENG Fuqing, PENG Shibo, WANG Liang
Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; 
Download: PDF(173 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract  Expression of DNA methyltransferase 1 (DNMT1), which plays an important role on aberrantly methylated CpG in the promoter regions of tumor suppressor genes (TSGs), is higher in bladder cancer cells than in normal bladder cells. Therefore, its overexpression is closely related to tumor formation. In this study, the eukaryotic vector pshRNA-DNMT1 was constructed and transfected into T24 cells. Levels of DNMT1 mRNA and protein were detected by reverse transcription-polymerase chain reaction (RT-PCR) and western blot. Relative to the blank control at the 24th, 48th and 72nd hour after transfection of pshRNA-DNMT1, the inhibitory rates of DNMT1 mRNA levels in T24 cells were 28.44%, 52.48%, 70.91%, respectively. Those of DNMT1 proteins were 24.27%, 57.79%, and 77.74%, respectively. Proliferation and apoptosis were assayed by MTT and flow cytometry with Annexin-V-FITC/PI staining. The growth inhibition rates of pshRNA-DNMT1 at the 24th, 48th and 72nd hour after transfection of pshRNA-DNMT1 were (4.34 ± 0.76)%, (9.87 ± 1.54)% and (13.78 ± 1.93)%, respectively. There were statistically significant differences between pshRNA-DNMT1 and the control blank at each time points (P < 0.01); 24, 48 and 72 hours after T24 cells were transfected by pshRNA-DNMT1, the apoptosis rates of pshRNA-DNMT1 were (3.87 ± 0.81)%, (8.69 ± 1.23)% and (11.46 ± 1.24)%, respectively (P < 0.01 vs blank control). Based on this case, our conclusion is that the recombinant plasmid pshRNA-DNMT1 can silence the expression of gene DNMT1 mRNA and protein effectively, and to some extent, it also can inhibit the proliferation of bladder cancer cell and promote the cellular apoptosis.
Issue Date: 05 December 2008
URL:     OR
1 Novik K L, Nimmrich I, Genc B, Maier S, Piepenbrock C, Olek A, Beck S . Epigenomics:genome-wide study of methylation phenomena. Curr Issues Mol Biol, 2002, 4(4): 111–128
2 Holliday R . Theinheritance of epigenetic defects. Science, 1987, 238(4824): 163–170.
3 Bonfils C, Beaulieu N, Chan E, Cotton-Montpetit J, MacLeod A R . Characterization of the humanDNA methyltransferase splice variant Dnmt1b. J Biol Chem, 2000, 275(15): 10754–10760.
4 Delaval K, Feil R . Epigenetic regulation ofmammalian genomic imprinting. Curr OpinGenet Dev, 2004, 14(2): 188–195.
5 Baylin S B . DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol, 2005, 2 Suppl1: S4–11.
6 Ehrlich M . Expressionof various genes is controlled by DNA methylation during mammaliandevelopment. J Cell Biochem, 2003, 88(5): 899–910.
7 Ting A H, Jair K W, Suzuki H, Yen R W, Baylin S B, Schuebel K E . Mammalian DNA methyltransferase 1: inspiration for new directions. Cell Cycle, 2004, 3(8): 1024–1026
8 Karpf A R, Matsui S . Genetic disruption of cytosineDNA methyltransferase enzymes induces chromosomal instability in humancancer cells. Cancer Res, 2005, 65(19): 8635–8639.
9 Bird A . DNAmethylation patterns and epigenetic memory. Genes Dev, 2002, 16(1): 6–21.
10 Li E . Chromatinmodification and epigenetic reprogramming in mammalian development. Nat Rev Genet, 2002, 3(9): 662–673.
11 Hermann A, Gowher H, Jeltsch A . Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci, 2004, 61(19–20): 2571–2587.
12 Robertson A K, Geiman T M, Sankpal U T, Hager G L, Robertson K D . Effects of chromatin structureon the enzymatic and DNA binding functions of DNA methyltransferasesDNMT1 and Dnmt3a in vitro. Biochem BiophysRes Commun, 2004, 322(1): 110–118.
13 El-Osta A . DNMTcooperativity–the developing links between methylation, chromatinstructure and cancer. Bioessays, 2003, 25(11): 1071–1084.
14 Etoh T, Kanai Y, Ushijima S, Nakagawa T, Nakanishi Y, Sasako M, Kitano S, Hirohashi S . Increased DNA methyltransferase 1 (DNMT1)protein expression correlates significantly with poorer tumor differentiationand frequent DNA hypermethylation of multiple CpG islands in gastriccancers. Am J Pathol, 2004, 164(2): 689–699
15 Chen C L, Yan X, Gao Y N, Liao Q P . Expressionof DNA methyltransferase 1, 3A and 3B mRNA in the epithelial ovariancarcinoma. Zhonghua Fuchanke Zazhi, 2005, 40(11): 770–774 (in Chinese)
16 Kn H, Bassal S, Tikellis C, El-Osta A . Expressionanalysis of the epigenetic methyltransferases and methyl-CpG bindingprotein families in the normal B-cell and B-cell chronic lymphocyticleukemia (CLL). Cancer Biol Ther, 2004, 3(10): 989–994
17 Nakagawa T, Kanai Y, Ushijima S, Kitamura T, Kakizoe T, Hirohashi S . DNA hypermethylation on multiple CpG islands associatedwith increased DNA methyltransferase DNMT1 protein expression duringmultistage urothelial carcinogenesis. JUrol, 2005, 173(5): 1767–1771.
18 Chen D R, Wang P L, Huang A L, Zhang B Q . Effects ofdnmt1 gene silencing on cell cycle proliferation and apoptosis ofgastric cancer cell line AGS. Ai Zheng, 2006, 25(3): 308–314 (in Chinese)
19 Ting A H, Jair K W, Suzuki H, Yen R W, Baylin S B, Schuebel K E . CpG island hypermethylation is maintained in human colorectal cancercells after RNAi-mediated depletion of DNMT1. Nat Genet, 2004, 36(6): 582–584.
20 Rhee I, Bachman K E, Park B H, Jair K W, Yen R W, Schuebel K E, Cui H, Feinberg A P, Lengauer C, Kinzler K W, Baylin S B, Vogelstein B . DNMT1and DNMT3b cooperate to silence genes in human cancer cells. Nature, 2002, 416(6880): 552–556.
No related articles found!
Full text